Claims
- 1. A method for quantifying hydration of living tissue non-invasively, based on in vivo spectral measurements, comprising the steps of:
providing a calibration set of exemplary samples and independent measurements, wherein a prediction model is developed from said calibration set; measuring a spectrum at a selected tissue measurement site on a living subject; estimating hydration of said tissue measurement site from said spectrum according to said prediction model.
- 2. The method of claim 1, wherein said spectral measurements comprise NIR spectra.
- 3. The method of claim 1, wherein said measurements are made using any of transmissive, diffuse reflectance and other methods, and wherein parameters for said method are determined based on information provided by said calibration set.
- 4. The method of claim 1, wherein said spectrum is denoted by a vector mεN of absorbance values pertaining to a set of N wavelengths λεN spanning a wavelength region of approximately 700 to 2500 nm.
- 5. The method of claim 1, further comprising the step of:
detecting outliers, wherein said outliers comprise invalid measurements.
- 6. The method of claim 5, wherein said invalid measurements result from any of instrument problems, poor sampling technique, and subjects outside of the calibration data set.
- 7. The method of claim 5, wherein said outlier detection step comprises the steps of:
performing a principal components analysis (PCA) of said measured spectrum; and analyzing resulting residuals.
- 8. The method of claim 7, wherein said PCA comprises projecting said measured spectrum m onto five eigenvectors contained in a matrix o that were previously developed through a PCA of absorbance spectra from said exemplary data set, wherein the calculation is given by:
- 9. The method of claim 8, wherein residual, q, is determined according to:
- 10. The method of claim 1, further comprising the step of preprocessing said measured spectrum.
- 11. The method of claim 10, said preprocessing step including transformations that attenuate noise and instrumental variation.
- 12. The method of claim 11, wherein said preprocessing transformations include any of: scaling, normalization, smoothing, and filtering.
- 13. The method of claim 11, wherein a preprocessed measurement is determined according to:
- 14. The method of claim 1, wherein said estimating step includes any of multiple least squares regression (MLR), principle component regression (PCR), and partial least squares regression (PLR) analysis wherein the measurement yεN is processed according to:
- 15. The method of claim 1, wherein said step of measuring a spectrum at a selected tissue measurement site on a living subject comprises:
using an apparatus for measuring an NIR absorbance spectrum to measure said spectrum.
- 16. The method of claim 15, wherein said apparatus comprises an energy source, said energy source comprising a plurality of LED's, each of said LED's emitting energy at a different targeted wavelength within a wavelength range of approximately 700-2500 nm;
a sample probe head, said sample probe head comprising a subject interface and being substantially in contact with said tissue measurement site and delivering NIR energy emitted by said energy source to said tissue measurement site; and a reference probe head, said reference probe head delivering NIR energy emitted by said energy source to an internal reference standard having known spectral characteristics.
- 17. The method of claim 16, wherein said tissue measurement site comprises an area of the skin of said living subject.
- 18. The method of claim 17, wherein the absorbance spectrum is calculated by:
- 19. The method of claim 18, wherein said spectrum, m, is analyzed to detect outliers, said outliers comprising invalid measurements, or readings outside the range of said prediction model.
- 20. The method of claim 19, wherein said spectrum is preprocessed, said preprocessing step comprising:
multiplicative scatter correction (MSC), wherein said spectrum is processed through a rotation that fits it to a reference spectrum {overscore (m)} determined from said calibration set; and mean centering.
- 21. The method of claim 20, wherein said MSC step comprises the steps of:
fitting said spectrum via linear regression according to:m=a+{overscore (bm)}+e where a and b are the slope and intercept and e is the error in fit; and correcting said spectrum through: 8x=m-ab, where x is the preprocessed spectrum.
- 22. The method of claim 21, wherein said mean centering step comprises the steps of:
calculating a mean for each LED absorbance from said calibration set; subtracting said mean from each LED absorbance in the measured spectrum.
- 23. The method of claim 17, wherein said prediction model is a multiple linear regression (MLR) model for predicting Stratum Corneum hydration.
- 24. The method of claim 23, wherein the prediction calculation is given by:
- 25. The method of claim 24, wherein the coefficients are calculated by:
- 26. The method of claim 1, wherein said prediction model includes a preprocessing algorithm.
- 27. The method of claim 1, further comprising the step of developing said prediction model using factor-based analytical methods, wherein a set of abstract features is developed that is capable of representing spectral variation related to tissue hydration.
- 28. The method of claim 27, wherein said developing step comprises the steps of:
providing NIR absorbance spectra; selecting wavelengths from said spectra, wherein said spectra are sub-divided into one or more regions according to wavelength; preprocessing and normalizing said spectra, wherein spectral variation related to tissue hydration is enhanced; projecting said measurements onto one or more sets of previously determined factors, said factors comprising eigenvectors, to determine scores, wherein said scores constitute extracted features; and subjecting said scores to a prediction procedure, said procedure comprising any of linear discriminant analysis, SIMCA, k nearest neighbor, fuzzy classification, an artificial neural networks.
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application is a Continuation of U.S. patent application Ser. No. 09/669,781, filed on Sep. 25, 2000.
Continuations (1)
|
Number |
Date |
Country |
Parent |
09669781 |
Sep 2000 |
US |
Child |
10161197 |
May 2002 |
US |